Li Suyu, Pan Wuyuan, Song Jianrong, Zhen Lan, Chen Yusha, Liu Weijian, Zhang Yulong, Chen Lingsi, Huang Qiuyuan, Zheng Shixiong, Zheng Xiangqin
Department of Radiation Oncology, Fujian Maternity and Child Health Hospital, College of Clinical Medical for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.
Department of Gynecology, Fujian Maternity and Child Health Hospital, College of Clinical Medical for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.
Front Med (Lausanne). 2024 May 30;11:1401700. doi: 10.3389/fmed.2024.1401700. eCollection 2024.
Adenocarcinoma is a common histological subtype of cervical cancer, accounting for 10-15% of all cases. The prognosis of cervical adenocarcinoma with distant organ metastases remains unclear. Therefore, our study aimed to investigate the patterns and prognosis of distant organ metastasis in cervical adenocarcinoma.
We obtained data from the Surveillance, Epidemiology, and End Results (SEER) database spanning from 2010 to 2019. Cox regression, Kaplan-Meier, and log-rank analyses were conducted.
We observed that adenocarcinoma (AC) of the cervix primarily metastasizes to single organs, with a rate of 73.3%. The lungs are the most common organs of metastasis, followed by the liver and bones. Patients with bone metastases have a median survival period of 12 months, which is slightly longer compared to metastasis in other organs. Distant organ metastasis, age, positive lymph nodes, higher AJCC stages, larger tumor diameter, and higher cell grades are related to poor prognosis ( < 0.001). Furthermore, we have observed that surgical intervention, radiotherapy, and chemotherapy can potentially provide benefits for patients with distant organ metastases.
Metastasis is an independent prognostic factor for cervical adenocarcinoma patients. Surgery, radiotherapy, and chemotherapy can provide an overall survival advantage for patients with distant organ metastases.
腺癌是宫颈癌常见的组织学亚型,占所有病例的10% - 15%。宫颈腺癌伴远处器官转移的预后仍不明确。因此,我们的研究旨在探讨宫颈腺癌远处器官转移的模式及预后。
我们从监测、流行病学和最终结果(SEER)数据库获取了2010年至2019年的数据。进行了Cox回归、Kaplan - Meier分析和对数秩检验。
我们观察到宫颈腺癌主要转移至单一器官,转移率为73.3%。肺是最常见的转移器官,其次是肝和骨。骨转移患者的中位生存期为12个月,比其他器官转移患者的生存期略长。远处器官转移、年龄、阳性淋巴结、较高的美国癌症联合委员会(AJCC)分期、较大的肿瘤直径和较高的细胞分级与预后不良相关(P < 0.001)。此外,我们观察到手术干预、放疗和化疗可能为有远处器官转移的患者带来益处。
转移是宫颈腺癌患者的独立预后因素。手术、放疗和化疗可为有远处器官转移的患者提供总生存优势。